Washington Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Washington Trust CO

$2.83 Billion
Q3 2024

A detailed history of Washington Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Washington Trust CO holds 340 shares of REGN stock, worth $242,970. This represents 0.01% of its overall portfolio holdings.

Number of Shares

340

Previous 342 0.58%

Holding current value

$242,970

Previous $359,000 0.56%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$1024.09 - $1201.76 $2,048 - $2,403	-2 Reduced 0.58%	340 $357,000
Q4 2023 Jan 18, 2024	BUY	$775.18 - $881.7 $1,550 - $1,763	2 Added 0.59%	342 $300,000
Q3 2023 Oct 18, 2023	BUY	$692.45 - $844.37 $692 - $844	1 Added 0.29%	340 $279,000
Q2 2023 Jul 27, 2023	BUY	$700.03 - $830.35 $1,400 - $1,660	2 Added 0.59%	339 $243,000
Q1 2023 May 10, 2023	BUY	$680.49 - $826.97 $229,325 - $278,688	337 New	337 $276,000
Q1 2023 May 04, 2023	SELL	$680.49 - $826.97 $229,325 - $278,688	-337 Closed	0 $277,000
Q4 2022 Feb 08, 2023	SELL	$705.89 - $766.39 $705 - $766	-1 Reduced 0.3%	337 $243,000
Q1 2022 May 05, 2022	BUY	$595.12 - $698.43 $178,536 - $209,528	300 Added 789.47%	338 $236,000
Q4 2021 Feb 09, 2022	SELL	$543.48 - $670.97 $18.6 Million - $23 Million	-34,297 Reduced 99.89%	38 $24,000
Q3 2021 Nov 09, 2021	BUY	$574.03 - $680.96 $443,151 - $525,701	772 Added 2.3%	34,335 $20.8 Million
Q2 2021 Aug 05, 2021	BUY	$472.8 - $558.54 $672,794 - $794,802	1,423 Added 4.43%	33,563 $18.7 Million
Q1 2021 Apr 28, 2021	BUY	$446.73 - $548.2 $2.72 Million - $3.34 Million	6,097 Added 23.41%	32,140 $15.2 Million
Q4 2020 Feb 09, 2021	BUY	$478.3 - $607.98 $455,341 - $578,796	952 Added 3.79%	26,043 $12.6 Million
Q3 2020 Nov 05, 2020	SELL	$544.75 - $658.21 $321,402 - $388,343	-590 Reduced 2.3%	25,091 $14 Million
Q2 2020 Aug 04, 2020	SELL	$493.32 - $643.92 $2.48 Million - $3.23 Million	-5,021 Reduced 16.35%	25,681 $16 Million
Q1 2020 May 07, 2020	BUY	$336.18 - $494.43 $404,424 - $594,799	1,203 Added 4.08%	30,702 $15 Million
Q4 2019 Feb 12, 2020	BUY	$274.13 - $376.51 $8.09 Million - $11.1 Million	29,499 New	29,499 $11.1 Million
Q3 2018 Nov 13, 2018	SELL	$351.14 - $408.51 $81,113 - $94,365	-231 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$284.6 - $344.99 $65,742 - $79,692	231 New	231 $80,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.

Account

Washington Trust CO Regeneron Pharmaceuticals, Inc. Transaction History